Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablationJasmeet S. Reyat, Larissa Fabritz, Paulus Kirchhof et al.|JCI Insight|2020Cited by 93
An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditionsWinnie Chua, Larissa Fabritz, Stéphane Hatem et al.|Scientific Reports|2023Cited by 28
Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation studyWinnie Chua, Larissa Fabritz, André Ziegler et al.|PLoS Medicine|2021Cited by 18